| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.059 | 0.3 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |